These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21955249)

  • 1. The hepatic reductase null mouse as a model for exploring hepatic conjugation of xenobiotics: application to the metabolism of diclofenac.
    Pickup K; Gavin A; Jones HB; Karlsson E; Page C; Ratcliffe K; Sarda S; Schulz-Utermoehl T; Wilson I
    Xenobiotica; 2012 Feb; 42(2):195-205. PubMed ID: 21955249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic fate of [14C]-fenclozic acid in the hepatic reductase null (HRN) mouse.
    Pickup K; Wills J; Rodrigues A; Jones HB; Page C; Martin S; Sarda S; Wilson I
    Xenobiotica; 2014 Jan; 44(2):164-73. PubMed ID: 24320884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac metabolism in the mouse: novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry.
    Sarda S; Page C; Pickup K; Schulz-Utermoehl T; Wilson I
    Xenobiotica; 2012 Feb; 42(2):179-94. PubMed ID: 21955289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) mice.
    Grimsley A; Foster A; Gallagher R; Hutchison M; Lundqvist A; Pickup K; Wilson ID; Samuelsson K
    Biochem Pharmacol; 2014 Dec; 92(4):701-11. PubMed ID: 25450676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
    Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
    Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
    Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic effects of repeated oral administration of diclofenac to hepatic cytochrome P450 reductase null (HRN™) and wild-type mice.
    Akingbasote JA; Foster AJ; Wilson I; Sarda S; Jones HB; Kenna JG
    Arch Toxicol; 2016 Apr; 90(4):853-62. PubMed ID: 25820915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
    Levová K; Moserová M; Kotrbová V; Sulc M; Henderson CJ; Wolf CR; Phillips DH; Frei E; Schmeiser HH; Mares J; Arlt VM; Stiborová M
    Toxicol Sci; 2011 May; 121(1):43-56. PubMed ID: 21362632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse.
    Pass GJ; Carrie D; Boylan M; Lorimore S; Wright E; Houston B; Henderson CJ; Wolf CR
    Cancer Res; 2005 May; 65(10):4211-7. PubMed ID: 15899812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of salicylic acid and diclofenac on the medium-chain and long-chain acyl-CoA formation in the liver and brain of mouse.
    Kasuya F; Kazumi M; Tatsuki T; Suzuki R
    J Appl Toxicol; 2009 Jul; 29(5):435-45. PubMed ID: 19391105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the hepatic CYP reductase null mouse model and its potential application in drug discovery.
    Boggs JW; Hop CE; McNamara E; Deng Y; Messick K; West K; Choo EF
    Mol Pharm; 2014 Mar; 11(3):1062-8. PubMed ID: 24450768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity.
    Henderson CJ; Pass GJ; Wolf CR
    Toxicol Lett; 2006 Mar; 162(1):111-7. PubMed ID: 16343823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHPLC-MS-Based Lipidomic and Metabonomic Investigation of the Metabolic Phenotypes of Wild Type and Hepatic CYP Reductase Null (HRN) Mice.
    Gray N; Gethings LA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2020 Jul; 186():113318. PubMed ID: 32380354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide.
    Kumar S; Samuel K; Subramanian R; Braun MP; Stearns RA; Chiu SH; Evans DC; Baillie TA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):969-78. PubMed ID: 12438516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the metabolism and toxicity of styrene and styrene oxide in hepatic cytochrome P450 reductase deficient mice and CYP2F2 deficient mice.
    Carlson GP
    Toxicology; 2012 Apr; 294(2-3):104-8. PubMed ID: 22386858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver.
    Mutch DM; Crespy V; Clough J; Henderson CJ; Lariani S; Mansourian R; Moulin J; Wolf CR; Williamson G
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G63-72. PubMed ID: 16455785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
    Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
    Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme A thioester intermediate in rats.
    Olsen J; Li C; Skonberg C; Bjørnsdottir I; Sidenius U; Benet LZ; Hansen SH
    Drug Metab Dispos; 2007 May; 35(5):758-64. PubMed ID: 17303625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver.
    Wang M; Dickinson RG
    Drug Metab Dispos; 1998 Feb; 26(2):98-104. PubMed ID: 9456294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.